Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is CICLOPIROX OLAMINE, with a corresponding US DMF Number 11389.
Remarkably, this DMF maintains an Active status since its submission on March 17, 1995, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 29, 2015, and payment made on January 19, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II